Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00256048
Status:
COMPLETED
Last Update Posted:
2017-04-12
First Post:
2005-11-17
Brief Title:
Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients
Sponsor:
Melbourne Health
Organization:
Melbourne Health
Study Overview
Official Title:
Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if naso-jejunal feeding feeding beyond the stomach improves the efficacy of enteral feeding feeding into the gut in critically ill patients
The study hypothesis is that in patients who fail to establish enteral feeding via the nasogastric route introduction of nasojejunal feeding will lead to more effective enteral feeding than the current regime involving staged introduction of promotility agents
The study hypothesis is that in patients who fail to establish enteral feeding via the nasogastric route introduction of nasojejunal feeding will lead to more effective enteral feeding than the current regime involving staged introduction of promotility agents
Detailed Description:
The study examines the area of enteral feeding in critically ill patients Current standard enteral feeding practice is via a nasogastric with the addition of promotility agents for patients who fail to absorb their enteral nutrition
This study compares the efficacy of nasojejunal feeding feeding with nasogastric enteral feeding with the addition of promotility agents
The duration of feeding will be determined by the patients nutritional requirements and their general condition However the data will be collected for duration of enteral feeding 28 days or ICU discharge whichever occurs first
This study compares the efficacy of nasojejunal feeding feeding with nasogastric enteral feeding with the addition of promotility agents
The duration of feeding will be determined by the patients nutritional requirements and their general condition However the data will be collected for duration of enteral feeding 28 days or ICU discharge whichever occurs first
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None